Literature DB >> 9856345

Cloning and characterization of novel disintegrins from Agkistrodon halys venom.

D Park1, I Kang, H Kim, K Chung, D S Kim, Y Yun.   

Abstract

Snake venom disintegrins act as potent inhibitors of platelet aggregation. In this report, we isolated genes encoding novel members of disintegrins through the screening of Agkistrodon halys venom gland cDNA library. Subsequent characterization of positives revealed the presence of distinct disintegrins named salmosinl, 2, and 3, each containing a characteristic RGD/KGD sequence essential for the binding to integrins. Whereas salmosinl was identical to previously described salmosin purified from A. halys venom, salmosin2 and salmosin3 were predicted to be a novel, 73 amino acid protein with a KGD sequence, and an 80 amino acid protein with an additional 7th disulfide bond, respectively. Taken together, this is the first report describing 3 unique disintegrins, namely, salmosinl with RGD, salmosin2 with KGD and salmosin3 with 7 disulfide bonds are found in a single species of venom. Subsequently, to compare the platelet aggregation inhibitory potential of the recombinant protein with that of natural protein, salmosinl was expressed in E. coli and purified to homogeneity. Recombinant and natural salmosin1 inhibited the binding of alphaIIbbeta3 to fibrinogen with an almost identical IC50 value of 2.2 nM and 4.5 nM respectively. Moreover, recombinant salmosinl displayed an IC50 value approximately 5-fold lower than flavoridin, which was previously described as the most potent venom disintegrin so far. In conclusion, we identified 3 disintegrins with distinct properties through the molecular cloning approach and found that the recombinant salmosinl retained one of the most potent alphaIIbbeta3 antagonist activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9856345

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  8 in total

1.  Cloning, expression, and hemostatic activities of a disintegrin, r-mojastin 1, from the mohave rattlesnake (Crotalus scutulatus scutulatus).

Authors:  Elda E Sánchez; Sara E Lucena; Steven Reyes; Julio G Soto; Esteban Cantu; Juan Carlos Lopez-Johnston; Belsy Guerrero; Ana Maria Salazar; Alexis Rodríguez-Acosta; Jacob A Galán; W Andy Tao; John C Pérez
Journal:  Thromb Res       Date:  2010-07-02       Impact factor: 3.944

2.  Molecular cloning of disintegrin-like transcript BA-5A from a Bitis arietans venom gland cDNA library: a putative intermediate in the evolution of the long-chain disintegrin bitistatin.

Authors:  Paula Juárez; Simon C Wagstaff; Jenny Oliver; Libia Sanz; Robert A Harrison; Juan J Calvete
Journal:  J Mol Evol       Date:  2006-06-16       Impact factor: 2.395

3.  Snake venom disintegrins: novel dimeric disintegrins and structural diversification by disulphide bond engineering.

Authors:  Juan J Calvete; M Paz Moreno-Murciano; R David G Theakston; Dariusz G Kisiel; Cezary Marcinkiewicz
Journal:  Biochem J       Date:  2003-06-15       Impact factor: 3.857

4.  Amino acid sequence and homology modeling of obtustatin, a novel non-RGD-containing short disintegrin isolated from the venom of Vipera lebetina obtusa.

Authors:  M Paz Moreno-Murciano; Daniel Monleón; Juan J Calvete; Bernardo Celda; Cezary Marcinkiewicz
Journal:  Protein Sci       Date:  2003-02       Impact factor: 6.725

5.  cDNA cloning of a snake venom metalloproteinase from the eastern diamondback rattlesnake (Crotalus adamanteus), and the expression of its disintegrin domain with anti-platelet effects.

Authors:  Montamas Suntravat; Ying Jia; Sara E Lucena; Elda E Sánchez; John C Pérez
Journal:  Toxicon       Date:  2013-01-10       Impact factor: 3.033

Review 6.  Structure-Function Relationship of the Disintegrin Family: Sequence Signature and Integrin Interaction.

Authors:  Ariana A Vasconcelos; Jorge C Estrada; Victor David; Luciana S Wermelinger; Fabio C L Almeida; Russolina B Zingali
Journal:  Front Mol Biosci       Date:  2021-12-03

Review 7.  Recombinant and Chimeric Disintegrins in Preclinical Research.

Authors:  Victor David; Barbara Barbosa Succar; João Alfredo de Moraes; Roberta Ferreira Gomes Saldanha-Gama; Christina Barja-Fidalgo; Russolina Benedeta Zingali
Journal:  Toxins (Basel)       Date:  2018-08-07       Impact factor: 4.546

Review 8.  Exogenous Integrin αIIbβ3 Inhibitors Revisited: Past, Present and Future Applications.

Authors:  Danique L van den Kerkhof; Paola E J van der Meijden; Tilman M Hackeng; Ingrid Dijkgraaf
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.